Inter J Stomatol ›› 2017, Vol. 44 ›› Issue (5): 519-522.doi: 10.7518/gjkq.2017.05.005
• Periodontitis • Previous Articles Next Articles
Li Gege1, Pan Jiahui1, Tang Qiuling1, Liu Xinchan2, Hou Yubo1, Yu Weixian1
CLC Number:
| [1] Hajishengallis G, Darveau RP, Curtis MA. The keys-tone-pathogen hypothesis[J]. Nat Rev Microbiol, 2012, 10(10):717-725. [2] Hajishengallis G, Lamont RJ. Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts[J]. Trends Microbiol, 2016, 24(6):477-489. [3] Hajishengallis G. Periodontitis: from microbial im-mune subversion to systemic inflammation[J]. Nat Rev Immunol, 2015, 15(1):30-44. [4] Benedyk M, Mydel PM, Delaleu N, et al. Gingipains: critical factors in the development of aspiration pneumonia caused by Porphyromonas gingivalis [J]. J Innate Immun, 2016, 8(2):185-198. [5] Potempa J, Pike R, Travis J. Titration and mapping of the active site of cysteine proteinases from Por-phyromonas gingivalis (gingipains) using peptidyl chloromethanes[J]. Biol Chem, 1997, 378(3/4):223- 230. [6] Potempa J, Pike R, Travis J. The multiple forms of trypsin-like activity present in various strains of Por-phyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain[J]. Infect Im-mun, 1995, 63(4):1176-1182. [7] Wang M, Krauss JL, Domon H, et al. Microbial hijacking of complement-toll-like receptor crosstalk [J]. Sci Signal, 2010, 3(109):ra11. [8] Hajishengallis G, Abe T, Maekawa T, et al. Role of complement in host-microbe homeostasis of the pe-riodontium[J]. Semin Immunol, 2013, 25(1):65-72. [9] Hussain QA, McKay IJ, Gonzales-Marin C, et al. Detection of adrenomedullin and nitric oxide in dif-ferent forms of periodontal disease[J]. J Periodont Res, 2016, 51(1):16-25. [10] Liang S, Krauss JL, Domon H, et al. The C5a rece-ptor impairs IL-12-dependent clearance of Porphyro-monas gingivalis and is required for induction of periodontal bone loss[J]. J Immunol, 2011, 186(2): 869-877. [11] Hawlisch H, Belkaid Y, Baelder R, et al. C5a nega-tively regulates toll-like receptor 4-induced immune responses[J]. Immunity, 2005, 22(4):415-426. [12] Wu Z, Liu Y, Dong W, et al. CD14 in the TLRs signaling pathway is associated with the resistance to E. coli F18 in Chinese domestic weaned piglets[J]. Sci Rep, 2016, 6:24611. [13] Holden JA, Attard TJ, Laughton KM, et al. Por-phyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines[J]. Infect Immun, 2014, 82(10):4190-4203. [14] Lam RS, O’Brien-Simpson NM, Holden JA, et al. Unprimed, M1 and M2 macrophages differentially interact with Porphyromonas gingivalis [J]. PLoS ONE, 2016, 11(7):e0158629. [15] Wilensky A, Tzach-Nahman R, Potempa J, et al. Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection[J]. J Innate Immun, 2015, 7(2):127-135. [16] Abe T, Hosur KB, Hajishengallis E, et al. Local com-plement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor(CD88) antagonist [J]. J Immunol, 2012, 189(11):5442-5448. [17] Kataoka S, Baba A, Suda Y, et al. A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy [J]. FASEB J, 2014, 28(8):3564-3578. [18] Reynolds EC, O’Brien-Simpson N, Rowe T, et al. Prospects for treatment of Porphyromonas gingiva-lis -mediated disease—immune-based therapy[J]. J Oral Microbiol, 2015, 7:29125. |